Genprex Inc. [NASDAQ: GNPX] jumped around 0.34 points on Monday, while shares priced at $3.71 at the close of the session, up 10.09%. The company report on July 31, 2020 that Genprex to Present at Proactive’s One2One Virtual Investor Forum on August 4, 2020.
Company to provide update on its lead drug candidate, GPX-001 for non-small cell lung cancer, and its preclinical diabetes gene therapy candidate that may have the potential to cure Type 1 and Type 2 diabetes.
Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, announced today that the Company will present at the Proactive Investors One2One Virtual Event on August 4, 2020.
Genprex Inc. stock is now 1059.38% up from its year-to-date (YTD) trading value. GNPX Stock saw the intraday high of $3.86 and lowest of $3.36 per share. The company’s 52-week high price is 7.03, which means current price is +1,320.37% above from all time high which was touched on 02/25/20.
Compared to the average trading volume of 2.78M shares, GNPX reached a trading volume of 1074309 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Genprex Inc. [GNPX]?
Noble Capital Markets have made an estimate for Genprex Inc. shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on April 29, 2019.
The Average True Range (ATR) for Genprex Inc. is set at 0.34 The Price to Book ratio for the last quarter was 4.31, with the Price to Cash per share for the same quarter was set at 0.68.
How has GNPX stock performed recently?
Genprex Inc. [GNPX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -2.62. With this latest performance, GNPX shares gained by 22.44% in over the last four-week period, additionally plugging by 120.83% over the last 6 months – not to mention a rise of 290.53% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for GNPX stock in for the last two-week period is set at 57.53, with the RSI for the last a single of trading hit 59.35, and the three-weeks RSI is set at 57.39 for Genprex Inc. [GNPX]. The present Moving Average for the last 50 days of trading for this stock 3.16, while it was recorded at 3.54 for the last single week of trading, and 2.08 for the last 200 days.
Genprex Inc. [GNPX]: Deeper insight into the fundamentals
Return on Total Capital for GNPX is now -179.47, given the latest momentum, and Return on Invested Capital for the company is -179.00. Return on Equity for this stock declined to -179.00, with Return on Assets sitting at -166.44.
Reflecting on the efficiency of the workforce at the company, Genprex Inc. [GNPX] managed to generate an average of -$1,331,846 per employee.Genprex Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 33.20 and a Current Ratio set at 34.50.
Earnings analysis for Genprex Inc. [GNPX]
With the latest financial reports released by the company, Genprex Inc. posted -0.23/share EPS, while the average EPS was predicted by analysts to be reported at -0.13/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -76.90%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for GNPX.
Insider trade positions for Genprex Inc. [GNPX]
There are presently around $3 million, or 8.70% of GNPX stock, in the hands of institutional investors. The top three institutional holders of GNPX stocks are: VANGUARD GROUP INC with ownership of 303,399, which is approximately New of the company’s market cap and around 23.00% of the total institutional ownership; GEODE CAPITAL MANAGEMENT, LLC, holding 125,884 shares of the stock with an approximate value of $0.47 million in GNPX stocks shares; and SUSQUEHANNA INTERNATIONAL GROUP, LLP, currently with $0.32 million in GNPX stock with ownership of nearly New of the company’s market capitalization.
Positions in Genprex Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 25 institutional holders increased their position in Genprex Inc. [NASDAQ:GNPX] by around 853,341 shares. Additionally, 5 investors decreased positions by around 648,852 shares, while 2 investors held positions by with 605,441 shares. The mentioned changes placed institutional holdings at 896,752 shares, according to the latest SEC report filing. GNPX stock had 22 new institutional investments in for a total of 824,387 shares, while 3 institutional investors sold positions of 644,151 shares during the same period.